$8.44
At close: Sep 1, 5:00 PM EST
$8.44
N/A
After Hours: 5:19 PM EST
Xeris Biopharma Holdings Inc
XERSNASDAQ
Xeris Biopharma Holdings Earnings & Forecasts
Xeris Biopharma Holdings (XERS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Xeris Biopharma Holdings Guidance
Xeris Biopharma Holdings (XERS) last issued guidance on August 6, 2026 for fiscal year 2026. The company guided revenue in the range of $385M - $390M for the period.
Compared to prior guidance, Xeris Biopharma Holdings maintained its revenue forecast from a prior range of $380M - $390M.
Xeris Biopharma Holdings has issued 22 guidance updates between March 8, 2023 and August 6, 2026. During this period, the company raised its outlook 14 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.01 | $-0.01 | $0.04 | $0.01 |
| Actual | $0.00 | $0.01 | $0.06 | $0.00 |
| Surprise | -100.0% | +200.0% | +50.0% | -100.0% |
| Revenue | ||||
| Estimate | $90.4M | $80.0M | $84.2M | $74.3M |
| Actual | $92.1M | $83.1M | $85.8M | $74.4M |
| Surprise | +1.84% | +3.91% | +1.94% | +0.17% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.01 | $0.14 | $0.03 | $0.09 |
| Revenue | ||||
| Consensus | $101.4M | $110.6M | — | — |
